Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2000-12-22
2002-12-24
Lankford, Jr., Leon B. (Department: 1651)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S729000, C424S641000, C424S643000, C424S646000, C424S682000, C424S702000, C514S458000, C514S052000
Reexamination Certificate
active
06497885
ABSTRACT:
BACKGROUND OF THE INVENTION
Because of delayed child bearing, unhealthy diets and use of tobacco, caffeine, alcohol, drugs and environmental contaminants, difficulties in conceiving have been experienced.
Needs exist for pharmaceutical compounds that improve fertility in both women and men.
SUMMARY OF THE INVENTION
This invention provides combinations of bioeffecting compounds for promoting fertility in men and women. The combinations include nutritional components that benefit fertility health. All the components have been studied separately, to determine their individual efficacy. The invention provides the first products to put these components together synergistically in women's and men's formulations.
As many as 15% of couples in the U.S. have difficulty conceiving a child. In about one third of these cases, it is the man that is infertile; in another third, the female has fertility issues. The remaining is due to a combination of male and female fertility issues, or unknown causes. In many of these cases, causes of infertility are treatable. Nutritional and lifestyle changes should be the first step to increasing chances for conception. Smoking and caffeine, drug and alcohol consumption, environmental toxicants, and stress are related to infertility in men and women. Reproductive organs are highly susceptible to free radical or oxidative damage from environmental toxicants and natural aging. A balanced, nutritional diet, and nutritional supplements with high antioxidant content can help reverse some of that damage. In women, hormone balance is critical to monthly ovulation and development of the corpus luteum (an ovarian follicle that release progesterone after release of the egg to prepare the uterus for implantation).
REFERENCES:
patent: 3970750 (1976-07-01), Brockemeyer et al.
patent: 4154813 (1979-05-01), Kleinberg
patent: 4340592 (1982-07-01), Adibi
patent: 4388325 (1983-06-01), Orzalesi
patent: 4599232 (1986-07-01), Bertelli
patent: 4920098 (1990-04-01), Cotter et al.
patent: 4954526 (1990-09-01), Keefer
patent: 5032608 (1991-06-01), Dudrick
patent: 5034377 (1991-07-01), Adibi et al.
patent: 5106836 (1992-04-01), Clemens et al.
patent: 5157022 (1992-10-01), Barbul
patent: 5171217 (1992-12-01), March et al.
patent: 5278189 (1994-01-01), Rath et al.
patent: 5364644 (1994-11-01), Walaszek et al.
patent: 5385937 (1995-01-01), Stamler et al.
patent: 5411956 (1995-05-01), Miyazaki et al.
patent: 5439938 (1995-08-01), Snyder et al.
patent: 5464644 (1995-11-01), Wullschleger et al.
patent: 5500266 (1996-03-01), Durnin
patent: 5523087 (1996-06-01), Shlyankevich
patent: 5543430 (1996-08-01), Kaesemeyer
patent: 5576287 (1996-11-01), Zaloga et al.
patent: 5576351 (1996-11-01), Yoshimura et al.
patent: 5594032 (1997-01-01), Gonzalez-Cadavid et al.
patent: 5626883 (1997-05-01), Paul
patent: 5631031 (1997-05-01), Meade
patent: 5650418 (1997-07-01), Rath et al.
patent: 5730987 (1998-03-01), Omar
patent: 5767160 (1998-06-01), Kaesemeyer
patent: 5780039 (1998-07-01), Greenberg et al.
patent: 5852058 (1998-12-01), Cooke et al.
patent: 5861168 (1999-01-01), Cooke et al.
patent: 5897864 (1999-04-01), Cohen
patent: 5977073 (1999-11-01), Khaled
patent: 6007824 (1999-12-01), Duckett et al.
patent: 0546796 (1993-06-01), None
patent: 58-55418 (1983-04-01), None
patent: 05-163139 (1993-06-01), None
patent: 06-321786 (1994-11-01), None
patent: WO94/01006 (1994-01-01), None
Kubo et al. J. Agric. Food Chem. (1992), vol. 40, No. 2, pp. 245-248.*
Pepeljnjak et al. Acta Pharm. (1996), vol. 46, pp. 201-206.*
Balch, James F. & Balch, Phyllis A.; Impotence, entry in Prescription for Nutritional Healing, 2nd Ed.; Copyright 1997, pp. 338-339.
Paick et al.; An experimental study of the effect of gingko biloba extract on the human and rabbit corpus cavernosum tissue; The Journal of Urology, vol. 156, Nov. 1996; pp. 1876-1880.
Internet Search Results, WedMD Health; Search Topics; “amino” amino acid; Branched-chain Amino Acids; Nonessential Amino Acids; Ginkgo; Ginseng; Protein in Diet; Want a Love Potion?; http://my.webmd.com; Jul. 23, 2001; 19 pages.
Internet Search Results, Auravita Health Channel; Search Topics: Arginine: Asian Ginseng; Dehydroepiandrosterone(DHEA); Ginkgo biliba; Impotence; www.auravita.com. Jul. 23, 2001, 17 pages.
Kaplan et al.; Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction;; Urology, vol. 53, 1999; pp. 481-486.
Article Query, Pubmed medline; Berman et al.; Effect of Estrogen withdrawal . . . (Urology, 1988); Goldstein et al., Vasculogenic female sexual dysfunction (IntJlmpotRes, 1998); Rosen et al., Effect of SSRIs on sexual function(JClin Psychphar, 1999); Pau et al., Dietary arginine . . . (JNutr. 1982) (Abstracts).
Brown, Donald J. Vitex agnus castus Clinical Monograph, Townsend Letter for Doctors and Patients, Oct. 1995, pp. 138-142.
Various, Study Abstracts and Results re Vitex, Phytotherapy Research Compendium, pp. 23 and 24. 1994.
Caan et al.; Differences in Fertility Associated with Caffeinated Beverage Consumption, American Journal of Public Health, vol. 88, No. 2, Feb., 1998: pp. 270-274.
Costa et al., L-carnitine in ideopathic asthenospermia: a multicenter study, Andologia, vol. 26, Jan. 1994: pp. 155-159.
Zheng et al., Effects of Ferulic Acid on Fertile and Asthenozoospermic Infertile Human Sperm Motility, Viability, Lipid Peroxidation, and Cyclic Nucleotides, Free Radical Biology and Medicine, vol. 22, No. 4, 1997: pp. 581-586.
Kessopoulou et al., A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility, Fertility and Sterility, vol. 64, No. 4, Oct. 1995: pp. 825-831.
Bayer, Treatment of Infertility with Vitamin E, International Journal of Fertility, vol. 5, No. 1, Jan.-Mar. 1960: pp. 70-78.
Geva et al., The effect of antioxidant treatment on human spermatazoa and fertilization rate in an in vitro fertilization program, Fertility and Sterility, vol. 66, No. 3, Sep. 1996: pp. 430-434.
Dawson et al., Effect of ascorbic acid supplementation on the sperm quality of smokers, Fertility and Sterility, vol. 58, No. 5, Nov. 1992: pp. 1034-1039.
Scott et al., The effect of oral selenium supplementation on human sperm motility, British Journal of Urology, vol. 82, 1998: pp. 76-80.
Internet Search Results, National Library of Medicine, Search Topics: Vitamin B12 and oligospermia: Zinc sulphate and infertility: Zinc and sperm count; FOlate and human fertility, www.ncbi.nlm.nih.gov/entrez, Mar. 29, 2000-Apr. 5, 2000, 7 pages.
Coe Susan D.
Creighton Wray James
Lankford , Jr. Leon B.
Narasimhan Meera P.
The Daily Wellness Company
LandOfFree
Method and composition for improving fertility health in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for improving fertility health in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for improving fertility health in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2918364